These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28331032)

  • 1. Impact of interferon-γ release assay on the latent tuberculosis cascade of care: a population-based study.
    Roth DZ; Ronald LA; Ling D; Chiang LY; Cook VJ; Morshed MG; Johnston JC
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28331032
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H; Yuen CS; Yip RM
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country.
    Bourgarit A; Baron G; Breton G; Tattevin P; Katlama C; Allavena C; Campa P; Ravaud P; Lortholary O; Carcelain G;
    Ann Am Thorac Soc; 2015 Aug; 12(8):1138-45. PubMed ID: 26213798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Latent Tuberculosis Infection: A Key Step Toward Achieving Tuberculosis Elimination in the United States.
    Reves R; Daley CL
    JAMA Intern Med; 2016 Oct; 176(10):1439-1440. PubMed ID: 27599130
    [No Abstract]   [Full Text] [Related]  

  • 5. Testing International Adoptees for Tuberculosis.
    Priya Dhar C; Elena Gonzalez B; Dragga T; Bothe D; Mandalakas AM
    Pediatr Infect Dis J; 2015 Oct; 34(10):1138-9. PubMed ID: 26367807
    [No Abstract]   [Full Text] [Related]  

  • 6. End TB Strategy: Time to Move on From the Skin Test to the Interferon-
    Kruse M; Cruikshank W
    Am J Public Health; 2019 Aug; 109(8):1102-1104. PubMed ID: 31268768
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of latent tuberculosis infection among healthcare workers in China as detected by two interferon-gamma release assays.
    Wei Z; Yang M; Quan B; Wang Y; Wu Y; Ji B
    J Hosp Infect; 2013 Aug; 84(4):323-5. PubMed ID: 23806839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
    Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
    Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of the use of a negative interferon-γ release assay for tuberculosis screening before TNF antagonist therapy.
    Woodfield G; Passey-Heaton B; Chakrabarti A; Pozniak A; Loebinger MR
    Eur Respir J; 2014 Nov; 44(5):1369-72. PubMed ID: 25186258
    [No Abstract]   [Full Text] [Related]  

  • 10. Tuberculin skin test and/or interferon gamma release assay: is it still time to debate?
    Sanduzzi A; Marchetiello I; Bocchino M; Boccia G; De Caro F
    Infez Med; 2017 Mar; 25(1):80-81. PubMed ID: 28353462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of Interferon-gamma Release Assays in the Screening of Latent Tuberculosis Infection in Immigrant and Internationally Adopted Children.
    Méndez-Echevarría A; Sainz T; García-Hortelano M; Baquero-Artigao F; Mellado MJ
    Pediatr Infect Dis J; 2015 Oct; 34(10):1141-2. PubMed ID: 26367809
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The frequency of tuberculosis chemoprophylaxis prior to TNF-α inhibitor treatment, and the incidence tuberculosis infection using a two-step screening algorithm for latent tuberculosis infection: data from the BioRx.si registry.
    Tomsic M; Rotar Z
    Ann Rheum Dis; 2012 Nov; 71(11):1909-11. PubMed ID: 22805974
    [No Abstract]   [Full Text] [Related]  

  • 14. Testing for latent tuberculosis infection using interferon gamma release assays in commercial sex workers at an outreach clinic in Birmingham.
    Daly R; Khatib N; Larkins A; Dedicoat M
    Int J STD AIDS; 2016 Jul; 27(8):676-9. PubMed ID: 26589629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deployment-related testing and treatment for latent tuberculosis infection, part II.
    Mancuso JD; Keep LW
    Mil Med; 2011 Oct; 176(10):1088-92. PubMed ID: 22128639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating Latent Tuberculosis Infection Using Interferon-γ Release Assay, Japan.
    Nishimura T; Ota M; Mori M; Hasegawa N; Kawabe H; Kato S
    Emerg Infect Dis; 2018 Nov; 24(11):2111-2113. PubMed ID: 30334726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contact tracing in low-incidence tuberculosis settings.
    van Leth F; Borgdorff M
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1566. PubMed ID: 22118163
    [No Abstract]   [Full Text] [Related]  

  • 20. Living donor and recipient screening for latent tuberculosis infection by tuberculin skin test and interferon-gamma releasing assay in a country with an intermediate burden of tuberculosis.
    Moon SM; Park IA; Kim SM; Park SJ; Jung JH; Kim YH; Park JB; Hong B; Lee SO; Choi SH; Kim YS; Woo JH; Park SK; Lee SK; Park JS; Han DJ; Kim SH
    J Infect Chemother; 2013 Oct; 19(5):1009-13. PubMed ID: 23917533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.